+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Erythromycins"

From
Global and Chinese Erythromycin Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Erythromycin Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 149 Pages
  • China, Global
From
From
Antibiotic Drug Resistance. Edition No. 1 - Product Thumbnail Image

Antibiotic Drug Resistance. Edition No. 1

  • Book
  • October 2019
  • 720 Pages
  • 8 Results (Page 1 of 1)
Loading Indicator

Erythromycins are a class of antibiotics used to treat a wide range of bacterial infections. They are derived from the bacterium Saccharopolyspora erythraea and are effective against Gram-positive bacteria, including Streptococcus, Staphylococcus, and Corynebacterium species. Erythromycins are also used to treat some Gram-negative bacteria, such as Haemophilus influenzae and Neisseria gonorrhoeae. They are available in various forms, including tablets, capsules, suspensions, and injections. Erythromycins are generally well-tolerated and have fewer side effects than other antibiotics. However, they can cause gastrointestinal upset, including nausea, vomiting, and diarrhea. They can also interact with other medications, so it is important to discuss any potential interactions with a healthcare provider before taking them. Some companies that produce erythromycins include Pfizer, Merck, GlaxoSmithKline, and AstraZeneca. Show Less Read more